Young-Chan Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Young-Chan Kim has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- Woo-Jung Song
Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
9 shared publications - Ha-Kyeong Won
Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju 28644, Korea
7 shared publications - Sang-Heon Kim
Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea
7 shared publications - Hye-Ryun Kang
Drug safety Center, Seoul National University Hospital, Seoul, Korea
6 shared publications - Noeul Kang
Division of Allergy, Department of Medicine Samsung Medical Center, Sungkyunkwan University School of Medicine Seoul South Korea
6 shared publications - Sang-Heon Cho
Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
6 shared publications
Latest Publications
- Open Access
- 23 July 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
Interpretive framework for Cough Hypersensitivity Questionnaire scores in chronic cough
Extract Chronic cough (>8 weeks) is a prevalent condition that substantially impairs quality of life (QoL) [1, 2]. While some cases are attributable to identifiable etiologies, chronic cough that remains unexplained or persists despite treatment of associated conditions represents an important unmet medical need [3]. Cough hypersensitivity has recently emerged as a key pathophysiological feature and treatable trait in these patients [4–7].
- 23 July 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
Open AccessInterpretive framework for Cough Hypersensitivity Questionnaire scores in chronic cough
Extract Chronic cough (>8 weeks) is a prevalent condition that substantially impairs quality of life (QoL) [1, 2]. While some cases are attributable to identifiable etiologies, chronic cough that remains unexplained or persists despite treatment of associated conditions represents an important unmet medical need [3]. Cough hypersensitivity has recently emerged as a key pathophysiological feature and treatable trait in these patients [4–7].
- Open Access
- 27 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Systemic atopy and upper-airway disease define susceptibility to incident asthma after COVID-19 in Korea
Incident asthma is an important respiratory sequela after COVID-19, but it is unclear which allergic phenotypes amplify risk. Using a linked nationwide Korean database of 3,987,182 individuals with confirmed severe acute respiratory syndrome coronavirus 2 infection, we compare claims-based incident asthma in those with pre-existing systemic atopy and/or upper-airway disease (allergic rhinitis, chronic rhinosinusitis, atopic dermatitis or food allergy) versus those without after 1:1 propensity score matching. During follow-up to 31 December 2022, participants with pre-existing disease have higher asthma incidence than matched controls (3.55 vs 2.13 per 1,000 person-years), with a hazard ratio of 1.66 (95% confidence interval 1.58–1.75). Asthma risk is elevated for each condition and increases with greater disease burden. These findings show that pre-existing allergic and upper-airway phenotypes stratify post-COVID incident asthma risk on a national scale, supporting targeted surveillance in high-risk subgroups.
- 27 June 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessSystemic atopy and upper-airway disease define susceptibility to incident asthma after COVID-19 in Korea
Incident asthma is an important respiratory sequela after COVID-19, but it is unclear which allergic phenotypes amplify risk. Using a linked nationwide Korean database of 3,987,182 individuals with confirmed severe acute respiratory syndrome coronavirus 2 infection, we compare claims-based incident asthma in those with pre-existing systemic atopy and/or upper-airway disease (allergic rhinitis, chronic rhinosinusitis, atopic dermatitis or food allergy) versus those without after 1:1 propensity score matching. During follow-up to 31 December 2022, participants with pre-existing disease have higher asthma incidence than matched controls (3.55 vs 2.13 per 1,000 person-years), with a hazard ratio of 1.66 (95% confidence interval 1.58–1.75). Asthma risk is elevated for each condition and increases with greater disease burden. These findings show that pre-existing allergic and upper-airway phenotypes stratify post-COVID incident asthma risk on a national scale, supporting targeted surveillance in high-risk subgroups.
- Open Access
- 23 April 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (5)
Prevalence and associated factors of cough syncope in patients with chronic cough: a multicentre prospective study
Cough syncope is a clinically significant complication of coughing, yet its epidemiology in patients with chronic cough remains poorly characterized. This study aimed to estimate the prevalence and identify associated factors for cough syncope among patients with chronic cough. Data were analysed from the Korean Chronic Cough Registry, a multicentre prospective observational study. Adults with newly referred chronic cough were followed for one year. Cough syncope was defined based on patient self-reports at enrolment and the one-year follow-up visit. We compared clinical characteristics between patients with and without cough syncope and performed multivariable logistic regression to identify independent associated factors. Among 682 eligible participants, cough syncope was identified in 13 (1.9%, 95% CI, 1.0–3.2%). Patients with cough syncope were predominantly male (69.2% versus 31.1%; p=0.014) and had a higher median body mass index (30.5 versus 23.8 kg·m −2 ; p=0.001) compared to those without. They also exhibited a higher rate of refractory chronic cough (RCC) (84.6% versus 46.2%; p=0.006) and reported greater cough severity and hypersensitivity at one year, despite more frequent use of neuromodulators and opiates. Multivariable analysis identified obesity (adjusted odds ratio [aOR] 4.65, 95% CI 1.24–17.47), RCC (aOR 4.08, 95% CI 1.09–15.23), and male sex (aOR 3.66, 95% CI 1.06–12.68) as independently associated with cough syncope. Cough syncope affects approximately 2% of patients with chronic cough and is associated with male sex, obesity, and refractory chronic cough, defining a distinct high-risk phenotype that warrants targeted risk stratification and prevention.
- 23 April 2026
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (5)
Open AccessPrevalence and associated factors of cough syncope in patients with chronic cough: a multicentre prospective study
Cough syncope is a clinically significant complication of coughing, yet its epidemiology in patients with chronic cough remains poorly characterized. This study aimed to estimate the prevalence and identify associated factors for cough syncope among patients with chronic cough. Data were analysed from the Korean Chronic Cough Registry, a multicentre prospective observational study. Adults with newly referred chronic cough were followed for one year. Cough syncope was defined based on patient self-reports at enrolment and the one-year follow-up visit. We compared clinical characteristics between patients with and without cough syncope and performed multivariable logistic regression to identify independent associated factors. Among 682 eligible participants, cough syncope was identified in 13 (1.9%, 95% CI, 1.0–3.2%). Patients with cough syncope were predominantly male (69.2% versus 31.1%; p=0.014) and had a higher median body mass index (30.5 versus 23.8 kg·m −2 ; p=0.001) compared to those without. They also exhibited a higher rate of refractory chronic cough (RCC) (84.6% versus 46.2%; p=0.006) and reported greater cough severity and hypersensitivity at one year, despite more frequent use of neuromodulators and opiates. Multivariable analysis identified obesity (adjusted odds ratio [aOR] 4.65, 95% CI 1.24–17.47), RCC (aOR 4.08, 95% CI 1.09–15.23), and male sex (aOR 3.66, 95% CI 1.06–12.68) as independently associated with cough syncope. Cough syncope affects approximately 2% of patients with chronic cough and is associated with male sex, obesity, and refractory chronic cough, defining a distinct high-risk phenotype that warrants targeted risk stratification and prevention.
- Open Access
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (4) , 507-524
KAAACI Consensus Document on the Goals and Standards of Chronic Cough Clinics in Korea: A Delphi Study
Kim MY, et al. Allergy Asthma Immunol Res. 2026 Jul;18(4):507-524. https://doi.org/10.4168/aair.2026.18.4.507
- 1 January 2026
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 18 (4) , 507-524
Open AccessKAAACI Consensus Document on the Goals and Standards of Chronic Cough Clinics in Korea: A Delphi Study
Kim MY, et al. Allergy Asthma Immunol Res. 2026 Jul;18(4):507-524. https://doi.org/10.4168/aair.2026.18.4.507
- Open Access
- 27 February 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (4)
Treatable traits in chronic cough: a prospective evaluation for predicting cough persistence
Background: The concept of treatable traits has been proposed for managing chronic cough; however, evidence supporting its clinical utility remains limited. This study investigated the relationship between baseline traits and cough persistence in a prospective registry of patients with chronic cough. Methods: We analysed data from 426 patients with chronic cough enrolled in the Korean Chronic Cough Registry. 11 potential treatable traits were assessed at baseline. The primary outcome was cough persistence, defined as a cough severity visual analogue scale (VAS) score >20 at the last follow-up visit. Results: After a median follow-up of 12 months (interquartile range: 6–24 months), 215 patients (50.5%) had persistent cough (VAS >20 mm). The most prevalent traits were sputum production (60.5%), cough hypersensitivity symptoms (41.8%) and type 2 inflammation (39.1%). Among baseline traits, only cough hypersensitivity symptoms were significantly associated with cough persistence (p=0.024). In multivariate analysis, cough hypersensitivity symptoms (adjusted OR 1.78, 95% CI 1.15–2.78; p=0.010) and older age (≥60 years) (adjusted OR 2.07, 95% CI 1.34–3.20; p=0.001) were independently associated with cough persistence. Conclusions: These findings suggest that cough hypersensitivity symptoms are associated with long-term outcomes of chronic cough. Further studies are needed to validate the role of treatable traits in chronic cough management and to better understand factors associated with cough persistence.
- 27 February 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 11 (4)
Open AccessTreatable traits in chronic cough: a prospective evaluation for predicting cough persistence
Background: The concept of treatable traits has been proposed for managing chronic cough; however, evidence supporting its clinical utility remains limited. This study investigated the relationship between baseline traits and cough persistence in a prospective registry of patients with chronic cough. Methods: We analysed data from 426 patients with chronic cough enrolled in the Korean Chronic Cough Registry. 11 potential treatable traits were assessed at baseline. The primary outcome was cough persistence, defined as a cough severity visual analogue scale (VAS) score >20 at the last follow-up visit. Results: After a median follow-up of 12 months (interquartile range: 6–24 months), 215 patients (50.5%) had persistent cough (VAS >20 mm). The most prevalent traits were sputum production (60.5%), cough hypersensitivity symptoms (41.8%) and type 2 inflammation (39.1%). Among baseline traits, only cough hypersensitivity symptoms were significantly associated with cough persistence (p=0.024). In multivariate analysis, cough hypersensitivity symptoms (adjusted OR 1.78, 95% CI 1.15–2.78; p=0.010) and older age (≥60 years) (adjusted OR 2.07, 95% CI 1.34–3.20; p=0.001) were independently associated with cough persistence. Conclusions: These findings suggest that cough hypersensitivity symptoms are associated with long-term outcomes of chronic cough. Further studies are needed to validate the role of treatable traits in chronic cough management and to better understand factors associated with cough persistence.
- Open Access
- 13 June 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (6)
Could cough hypersensitivity symptom profile differentiate phenotypes of chronic cough?
Background: Recently, cough reflex hypersensitivity has been proposed as a common underlying feature of chronic cough in adults. However, symptoms and clinical characteristics of cough hypersensitivity have not been studied amongst phenotypes of chronic cough. This study aimed to compare symptom features, such as cough triggers and associated throat sensations, of cough hypersensitivity in patients with asthmatic chronic cough and those with refractory chronic cough (RCC).Methods: Patients with chronic cough from the Korean Chronic Cough Registry were prospectively evaluated over 6 months. Physicians determined the aetiological diagnosis based on clinical evaluations and responses to treatment at the 6-month follow-up visit. Symptoms of cough hypersensitivity and cough-specific quality of life were assessed using the Cough Hypersensitivity Questionnaire (CHQ) and the Leicester Cough Questionnaire (LCQ), respectively.Results: The analysis included 280 patients who completed the follow-up: 79 with asthmatic cough (cough variant asthma or eosinophilic bronchitis) and 201 with RCC. Baseline CHQ scores were similar between the groups (8.3±3.7 in asthmatic coughversus8.9±3.9 in RCC; p=0.215, adjusted for age, sex and LCQ score). There were no significant between-group differences in the LCQ and cough severity Visual Analog Scale scores. Both groups showed a similar negative correlation with LCQ scores (asthmatic cough: r=−0.427, p<0.001; RCC: r=−0.306, p<0.001).Conclusions: The symptoms of cough hypersensitivity may not distinguish between asthmatic cough and RCC. This suggests that chronic cough is the primary diagnosis in both phenotypes. It indicates a shared mechanism in their cough pathogenesis, despite having potentially different treatable traits.
- 13 June 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (6)
Open AccessCould cough hypersensitivity symptom profile differentiate phenotypes of chronic cough?
Background: Recently, cough reflex hypersensitivity has been proposed as a common underlying feature of chronic cough in adults. However, symptoms and clinical characteristics of cough hypersensitivity have not been studied amongst phenotypes of chronic cough. This study aimed to compare symptom features, such as cough triggers and associated throat sensations, of cough hypersensitivity in patients with asthmatic chronic cough and those with refractory chronic cough (RCC).Methods: Patients with chronic cough from the Korean Chronic Cough Registry were prospectively evaluated over 6 months. Physicians determined the aetiological diagnosis based on clinical evaluations and responses to treatment at the 6-month follow-up visit. Symptoms of cough hypersensitivity and cough-specific quality of life were assessed using the Cough Hypersensitivity Questionnaire (CHQ) and the Leicester Cough Questionnaire (LCQ), respectively.Results: The analysis included 280 patients who completed the follow-up: 79 with asthmatic cough (cough variant asthma or eosinophilic bronchitis) and 201 with RCC. Baseline CHQ scores were similar between the groups (8.3±3.7 in asthmatic coughversus8.9±3.9 in RCC; p=0.215, adjusted for age, sex and LCQ score). There were no significant between-group differences in the LCQ and cough severity Visual Analog Scale scores. Both groups showed a similar negative correlation with LCQ scores (asthmatic cough: r=−0.427, p<0.001; RCC: r=−0.306, p<0.001).Conclusions: The symptoms of cough hypersensitivity may not distinguish between asthmatic cough and RCC. This suggests that chronic cough is the primary diagnosis in both phenotypes. It indicates a shared mechanism in their cough pathogenesis, despite having potentially different treatable traits.
- Open Access
- 16 May 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (5)
Exploring the concept of disease control in chronic cough
Background: Disease control in chronic diseases is an overarching concept that reflects the degree to which the goals of therapy are met. However, to date, there is no consensus on the definition of disease control in chronic cough. This study aimed to provide a conceptual exploration of patient-reported cough control in chronic cough.Methods: This research is comprised of two subanalyses. First, patients with chronic cough receiving care at referral clinics were evaluated. Correlation analyses were performed between patient-reported cough control (a 5-point Likert scale), cough-specific patient-reported outcomes (PROs) and generic health PRO scores. Second, a survey was conducted among patients with refractory chronic cough and physicians to identify factors pertinent to cough control.Results: The analysis of 341 patients (mean age: 55.5±15.1 years; female: 66.6%) revealed that cough control rating was moderately correlated with cough severity visual analogue scale and Leicester Cough Questionnaire scores, while demonstrating weaker correlations with cough-associated throat symptoms, cough-related complications or general health-related quality of life (QoL). In the survey of patients and physicians, both groups considered certain factors, such as cough frequency, severity and impact on QoL, to be relevant to the concept of cough control. However, patients rated “need for cough rescue drug” notably higher than physicians.Conclusion: Patient-reported cough control was associated with cough severity or impact on QoL; however, cough control may not be fully captured by conventional cough PRO measurement tools. Further studies are warranted to define the consensus and tools to measure disease control in chronic cough.
- 16 May 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (5)
Open AccessExploring the concept of disease control in chronic cough
Background: Disease control in chronic diseases is an overarching concept that reflects the degree to which the goals of therapy are met. However, to date, there is no consensus on the definition of disease control in chronic cough. This study aimed to provide a conceptual exploration of patient-reported cough control in chronic cough.Methods: This research is comprised of two subanalyses. First, patients with chronic cough receiving care at referral clinics were evaluated. Correlation analyses were performed between patient-reported cough control (a 5-point Likert scale), cough-specific patient-reported outcomes (PROs) and generic health PRO scores. Second, a survey was conducted among patients with refractory chronic cough and physicians to identify factors pertinent to cough control.Results: The analysis of 341 patients (mean age: 55.5±15.1 years; female: 66.6%) revealed that cough control rating was moderately correlated with cough severity visual analogue scale and Leicester Cough Questionnaire scores, while demonstrating weaker correlations with cough-associated throat symptoms, cough-related complications or general health-related quality of life (QoL). In the survey of patients and physicians, both groups considered certain factors, such as cough frequency, severity and impact on QoL, to be relevant to the concept of cough control. However, patients rated “need for cough rescue drug” notably higher than physicians.Conclusion: Patient-reported cough control was associated with cough severity or impact on QoL; however, cough control may not be fully captured by conventional cough PRO measurement tools. Further studies are warranted to define the consensus and tools to measure disease control in chronic cough.
- Open Access
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (6) , 690-700
Exploring Traits Associated With Central Sensitization Features in Patients With Chronic Cough
Jun H, et al. Allergy Asthma Immunol Res. 2024 Nov;16(6):690-700. https://doi.org/10.4168/aair.2024.16.6.690
- 1 January 2024
- Published by XMLink in Allergy, Asthma & Immunology Research
- Vol. 16 (6) , 690-700
Open AccessExploring Traits Associated With Central Sensitization Features in Patients With Chronic Cough
Jun H, et al. Allergy Asthma Immunol Res. 2024 Nov;16(6):690-700. https://doi.org/10.4168/aair.2024.16.6.690